| Literature DB >> 26788987 |
Ryusuke Honma1,2, Yuki Fujii1, Satoshi Ogasawara1, Hiroharu Oki1,2, Xing Liu1,2, Takuro Nakamura1, Mika K Kaneko1, Michiaki Takagi2, Yukinari Kato1.
Abstract
Podoplanin (PDPN) is a type I transmembrane O-glycoprotein, which is known as a specific lymphatic marker. PDPN activates platelet aggregation by binding to C-type lectin-like receptor-2 (CLEC-2) on platelet. PDPN is also expressed in several normal tissues, including podocytes and type I alveolar cells. Although many monoclonal antibodies (MAbs) against human PDPN (hPDPN), mouse PDPN (mPDPN), and rat PDPN (rPDPN) have been established, useful antibodies against rabbit PDPN (rabPDPN) have not been developed. In this study, we immunized mice with the recombinant proteins of rabPDPN, and developed a novel anti-rabPDPN MAb, named PMab-32. PMab-32 could detect endogenous and exogenous rabPDPN in flow cytometry and Western blot analysis. The KD of PMab-32 was determined to be 6.2 × 10(-8) M by flow cytometry. Immunohistochemical analysis showed that PMab-32 is useful for detecting podocytes, type I alveolar cells, and lymphatic endothelial cells in normal rabbit tissues. PMab-32 is expected to be useful for various rabbit experiments.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26788987 DOI: 10.1089/mab.2015.0066
Source DB: PubMed Journal: Monoclon Antib Immunodiagn Immunother ISSN: 2167-9436